Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02964182 · ClinicalTrials.gov registry record · NA

Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
213
Enrollment target

NCT02964182: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT02964182 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 213 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02964182, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
213 participants
Enrollment target

Study Summary

This trial studies what would happen if the nicotine levels in cigarettes are greatly reduced, but electronic cigarettes containing different amount of nicotine are available. Different levels of nicotine may effect certain behaviors, including withdrawal symptoms, nicotine cravings, and mood and may lead to changes in smoking behavior in current daily and intermittent smokers..

Primary Outcome

Mean usual brand cigarettes per day (CPD) smoked during the phase

Interventions

  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • DRUG Nicotine Replacement
  • DRUG Cigarette

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2017-10-26
Est. Completion 2025-03-04
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT02964182 record still lists

NCT02964182 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.

NCT02964182 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02964182 about?

NCT02964182 is a clinical study titled "Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers". This trial studies what would happen if the nicotine levels in cigarettes are greatly reduced, but electronic cigarettes containing different amount of nicotine are available. Different levels of nicotine may effect certain behaviors, including withdrawal symptoms, nicotine cravings, and mood and ma...

What is the current status of trial NCT02964182?

This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2017-10-26. Estimated completion is 2025-03-04.

What interventions are being tested in trial NCT02964182?

The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Nicotine Replacement (DRUG), Cigarette (DRUG).

Who is sponsoring clinical trial NCT02964182?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02964182's enrollment target sits among peer trials

213 488th of 2000 higher than 1,512 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06476886 · 213 participants · NA

    Intensive Crisis Intervention

  • NCT06544655 · 213 participants · Phase 1

    A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

  • NCT07186816 · 213 participants · NA

    SUpport From PEeRs to Expand Access Study - Community

  • NCT04030507 · 214 participants · NA

    Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02964182, the US trial registry maintained by the National Library of Medicine. NCT02964182 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.